$STZ

(STZ) Constellation Brands Expects Fiscal 2027 Adjusted EPS Range $11.20-$11.90, vs. FactSet Est of $11.71

Constellation Brands (STZ) forecasts adjusted EPS of $11.20-$11.90 for fiscal 2027, below FactSet's estimate of $11.71. The company also announced the acquisition of SpikedAde. STZ shares rose 2.08% in after-hours trading.

Original reporting
Published Oct 6, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STZ
Neutral
high confidence
Mentioned
$STZ
Relevance
8/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$STZNeutralHigh
01

Why it matters

The guidance range is the first public disclosure for FY2027, providing a new data point for valuation models and likely prompting short‑term price adjustments.

02

Market read

New EPS guidance for a large consumer staple company can move the stock and influence sector peers.

03

What to watch

Potential cost‑inflation pressures and upcoming product launches could drive earnings above the guidance range.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Constellation Brands is a leading beer, wine, and spirits producer with a market cap above $100 B. The FY2027 guidance update follows its FY2026 results and reflects expectations for its premium portfolio.

Company-level read

Ticker impact

$STZNeutralHigh confidence
Context

Constellation Brands released FY2027 adjusted EPS guidance of $11.20‑$11.90, deviating from the FactSet consensus of $11.71.

Expected impact

likely modest pressure as the market prices in the guidance range, with upside bias if the company hits the high end

Evidence & confidence

The new EPS range is the first public disclosure and directly influences valuation models; the range includes the consensus estimate, limiting dramatic moves.

Market effects

Beverage alcohol sector may see modest re‑rating as peers compare guidance against Constellation's outlook.

U.S. consumer discretionary market may experience slight adjustment in valuation multiples.

Limited global impact; primarily affects U.S. listed consumer staples investors.

Counterpoint

If the company can exceed the upper bound, the stock could rally sharply, contrary to the modest consensus view.

Key entities

  • Constellation Brands

    U.S. listed beverage alcohol producer (ticker STZ).

Related articles

$STZMed

STZ Maintained by Morgan Stanley -- Price Target Lowered to $145

Morgan Stanley maintained Constellation Brands (STZ) at Equal-Weight but lowered its price target to $145 from $158, citing a cautious outlook in the competitive beverage market. GuruFocus values STZ at $172.88, suggesting a 31.5% undervaluation at its current price of $118.39, with a P/E (TTM) of 10.62x. The company's GF Score is 59/100, indicating moderate overall performance.

$STZMed

Why is Constellation Brands stock sliding today?

Constellation Brands (STZ) fell 1.1% in pre-market trading after HSBC downgraded it to Hold and cut its price target to $135. The company's Q2 2027 earnings showed mixed results, with adjusted EPS of $3.74 and net sales of $2.63B beating estimates, but beer depletions fell 0.6%. Analysts had mixed reactions, with some cutting price targets but maintaining bullish ratings, while others kept Buy ratings. The broader market downturn also contributed to the slide.